This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Nexgenix Pharmaceuticals, Inc., Universitéde Strasbourg. Active years: 2012-2013.
Company Filing History:
3 out of 3 
1 out of 186 
Years Active: 2012-2013
Title: Allan E Rubenstein: Innovator in Neurofibroma Treatment
Introduction
Allan E Rubenstein is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical treatments, particularly in the area of neurofibromas. With a total of 3 patents to his name, his work has the potential to impact many lives.
Latest Patents
Rubenstein's latest patents include innovative methods for treating neurofibromas. One of his patents describes a method for locally treating neurofibromas, such as dermal and subdermal types, by applying a composition either topically or intralesionally. This method specifically avoids systemic administration, focusing instead on localized treatment. Another significant patent involves the treatment of neurofibromatosis using radicicol and its derivatives. This invention outlines compounds and methods for treating NF2-deficient or NF1-deficient cells, as well as neurodegenerative diseases. The methods include inhibiting the growth of tumors associated with these deficiencies.
Career Highlights
Throughout his career, Allan E Rubenstein has worked with various organizations, including Nexgenix Pharmaceuticals, Inc. and Université de Strasbourg. His experience in these companies has contributed to his expertise in developing innovative treatments.
Collaborations
Rubenstein has collaborated with notable colleagues such as Jin-Chen Yu and Ruihong Chen. These partnerships have likely enhanced his research and development efforts in the medical field.
Conclusion
Allan E Rubenstein's contributions to the treatment of neurofibromas and neurofibromatosis highlight his role as an influential inventor in the medical community. His innovative patents and collaborations reflect a commitment to advancing healthcare solutions.